Published in
Wiley, Diabetes, Obesity and Metabolism, 5(16), p. 451-456, 2013
DOI: 10.1111/dom.12240
Links
Tools
Dose response of continuous subcutaneous infusion of recombinant glucagon-like peptide-1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitus
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 